Skip to content Skip to footer

Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement

IQI Blog

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter